198,763 Shares in Merck KGaA $MKGAF Purchased by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab purchased a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 198,763 shares of the company’s stock, valued at approximately $25,541,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of MKGAF. Gables Capital Management Inc. purchased a new stake in Merck KGaA during the second quarter valued at about $2,095,000. Diversify Advisory Services LLC purchased a new position in shares of Merck KGaA in the second quarter worth approximately $3,810,000. Finally, Danske Bank A S purchased a new position in shares of Merck KGaA in the second quarter worth approximately $276,535,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Stock Up 1.2%

MKGAF stock opened at $160.21 on Wednesday. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56. The company’s 50 day simple moving average is $162.32 and its 200-day simple moving average is $148.21. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The firm has a market capitalization of $20.71 billion, a P/E ratio of 24.46 and a beta of 0.96.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.